Health Care & Life Sciences » Pharmaceuticals | Shanghai Shenqi Pharmaceutical Investment Management Co. Ltd.

Shanghai Shenqi Pharmaceutical Investment Management Co. Ltd. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
18,401.80
29,358.90
34,727.40
26,590.00
17,702.20
14,877.10
Depreciation, Depletion & Amortization
4,571.00
5,170.60
6,262.60
6,916.60
6,944.00
7,394.70
Other Funds
70,613.90
1,013.30
1,553.60
6,882.30
2,012.50
3,825
Funds from Operations
24,484.10
7,160.90
47,064.80
35,265.40
30,760.10
25,981.80
Changes in Working Capital
12,063.50
8,327.30
41,644.00
34,669.80
20,602.20
3,405.80
Net Operating Cash Flow
12,420.60
1,166.40
5,420.80
595.60
10,158.00
22,575.90
Capital Expenditures
9,040.90
9,797.90
10,529.40
6,453.40
16,104.90
Sale of Fixed Assets & Businesses
12.10
9.30
4.10
3,409.80
351.80
Purchase/Sale of Investments
-
-
156.30
698.80
812.40
Net Investing Cash Flow
975.80
9,745.10
7,651.60
2,895.40
16,565.50
Cash Dividends Paid - Total
-
-
4,589.20
5,235.40
2,367.90
Issuance/Reduction of Debt, Net
35,785.80
4,868.80
-
7,526.10
7,102.50
Net Financing Cash Flow
34,828.00
5,882.10
3,035.60
9,173.00
2,722.00
Net Change in Cash
48,224.40
5,029.40
5,266.30
6,873.20
3,685.50
Free Cash Flow
3,379.70
10,964.30
5,108.70
5,857.80
5,946.90
Deferred Taxes & Investment Tax Credit
426.90
19.00
3,772.10
591.00
622.90
115
Net Assets from Acquisitions
-
-
3,030.10
-
-
Other Sources
10,004.60
43.50
-
847.00
-
Exchange Rate Effect
0.00
0.00
0.00
0.00
0.00

About Shanghai Shenqi Pharmaceutical Investment Management Co.

View Profile
Address
Room 613, Changfa Building
Shanghai Shanghai 200003
China
Employees -
Website http://www.gzsq.com
Updated 07/08/2019
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. Its products include yening syrup, lipid detoxification, cardiovascular, high blood, and other medicines. The company was founded in 1947 and is headquartered in Shanghai, China.